25849550|t|G-CSF protects human brain vascular endothelial cells injury induced by high glucose, free fatty acids and hypoxia through MAPK and Akt signaling.
25849550|a|Granulocyte-colony stimulating factor (G-CSF) has been shown to play a neuroprotective role in ischemic stroke by mobilizing bone marrow (BM)-derived endothelial progenitor cells (EPCs), promoting angiogenesis, and inhibiting apoptosis. Impairments in mobilization and function of the BM-derived EPCs have previously been reported in animal and human studies of diabetes where there is both reduction in the levels of the BM-derived EPCs and its ability to promote angiogenesis. This is hypothesized to account for the pathogenesis of diabetic vascular complications such as stroke. Here, we sought to investigate the effects of G-CSF on diabetes-associated cerebral vascular defect. We observed that pretreatment of the cultured human brain vascular endothelial cells (HBVECs) with G-CSF largely prevented cell death induced by the combination stimulus with high glucose, free fatty acids (FFA) and hypoxia by increasing cell viability, decreasing apoptosis and caspase-3 activity. Cell ultrastructure measured by transmission electron microscope (TEM) revealed that G-CSF treatment nicely reduced combination stimulus-induced cell apoptosis. The results from fluorescent probe Fluo-3/AM showed that G-CSF greatly suppressed the levels of intracellular calcium ions under combination stimulus. We also found that G-CSF enhanced the expression of cell cycle proteins such as human cell division cycle protein 14A (hCdc14A), cyclinB and cyclinE, inhibited p53 activity, and facilitated cell cycle progression following combination stimulus. In addition, activation of extracellular signal-regulated kinase1/2 (ERK1/2) and Akt, and deactivation of c-Jun N terminal kinase (JNK) and p38 were proved to be required for the pro-survival effects of G-CSF on HBVECs exposed to combination stimulus. Overall, G-CSF is capable of alleviating HBVECs injury triggered by the combination administration with high glucose, FFA and hypoxia involving the mitogen-activated protein kinases (MAPK) and Akt signaling cascades. G-CSF may represent a promising therapeutic agent for diabetic stroke. 
25849550	0	5	G-CSF	Gene	1440
25849550	15	20	human	Species	9606
25849550	21	35	brain vascular	Disease	MESH:D002561
25849550	54	60	injury	Disease	MESH:D014947
25849550	77	84	glucose	Chemical	MESH:D005947
25849550	86	102	free fatty acids	Chemical	MESH:D005230
25849550	107	114	hypoxia	Disease	MESH:D000860
25849550	132	135	Akt	Gene	207
25849550	147	184	Granulocyte-colony stimulating factor	Gene	1440
25849550	186	191	G-CSF	Gene	1440
25849550	242	257	ischemic stroke	Disease	MESH:D002544
25849550	492	497	human	Species	9606
25849550	509	517	diabetes	Disease	MESH:D003920
25849550	682	713	diabetic vascular complications	Disease	MESH:D003925
25849550	722	728	stroke	Disease	MESH:D020521
25849550	776	781	G-CSF	Gene	1440
25849550	785	793	diabetes	Disease	MESH:D003920
25849550	805	829	cerebral vascular defect	Disease	MESH:D002532
25849550	877	882	human	Species	9606
25849550	883	897	brain vascular	Disease	MESH:D002561
25849550	930	935	G-CSF	Gene	1440
25849550	1011	1018	glucose	Chemical	MESH:D005947
25849550	1020	1036	free fatty acids	Chemical	MESH:D005230
25849550	1038	1041	FFA	Chemical	MESH:D005230
25849550	1047	1054	hypoxia	Disease	MESH:D000860
25849550	1110	1119	caspase-3	Gene	836
25849550	1215	1220	G-CSF	Gene	1440
25849550	1326	1332	Fluo-3	Chemical	MESH:C059715
25849550	1348	1353	G-CSF	Gene	1440
25849550	1401	1408	calcium	Chemical	MESH:D002118
25849550	1461	1466	G-CSF	Gene	1440
25849550	1522	1527	human	Species	9606
25849550	1602	1605	p53	Gene	7157
25849550	1714	1754	extracellular signal-regulated kinase1/2	Gene	5594
25849550	1756	1762	ERK1/2	Gene	5595;5594
25849550	1768	1771	Akt	Gene	207
25849550	1793	1816	c-Jun N terminal kinase	Gene	5599
25849550	1818	1821	JNK	Gene	5599
25849550	1827	1830	p38	Gene	5594
25849550	1890	1895	G-CSF	Gene	1440
25849550	1948	1953	G-CSF	Gene	1440
25849550	1987	1993	injury	Disease	MESH:D014947
25849550	2048	2055	glucose	Chemical	MESH:D005947
25849550	2057	2060	FFA	Chemical	MESH:D005230
25849550	2065	2072	hypoxia	Disease	MESH:D000860
25849550	2132	2135	Akt	Gene	207
25849550	2156	2161	G-CSF	Gene	1440
25849550	2210	2225	diabetic stroke	Disease	MESH:D003920
25849550	Association	MESH:D014947	1440
25849550	Positive_Correlation	MESH:D005230	MESH:D014947
25849550	Positive_Correlation	MESH:D000860	836
25849550	Association	1440	5594
25849550	Negative_Correlation	MESH:D005230	1440
25849550	Negative_Correlation	MESH:D002544	1440
25849550	Association	1440	5595
25849550	Association	1440	207
25849550	Negative_Correlation	MESH:D000860	1440
25849550	Association	MESH:D014947	207
25849550	Negative_Correlation	MESH:D002118	1440
25849550	Association	MESH:D000860	207
25849550	Negative_Correlation	1440	836
25849550	Positive_Correlation	MESH:D005230	MESH:D002561
25849550	Association	MESH:D005947	207
25849550	Negative_Correlation	1440	5599
25849550	Association	MESH:D002561	207
25849550	Negative_Correlation	1440	7157
25849550	Positive_Correlation	MESH:D005947	MESH:D014947
25849550	Association	MESH:D005230	207
25849550	Association	MESH:D002561	1440
25849550	Positive_Correlation	MESH:D005947	MESH:D002561

